AlloVir
ALVR
$0.75
Share price
-4.51%
Change (1 day)
-82.47%
Change (1 year)
Categories
AlloVir (ALVR) - P/B ratio
P/B ratio as of May 2024 : 0.5913
According to AlloVir's latest financial reports the company has a price-to-book ratio of 0.5913.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
AlloVir - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5319 | -75.01% |
| 2022-12-31 | 2.13 | -43.11% |
| 2021-12-31 | 3.74 | -44.26% |
| 2020-12-31 | 6.71 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.70 | 356.45% | 🇺🇸 USA |